Flexion Therapeutics
FLXN
#7787
Rank
โ‚น43.99 B
Marketcap
โ‚น874.27
Share price
0.00%
Change (1 day)
8,910.54%
Change (1 year)

Earnings for Flexion Therapeutics (FLXN)

Earnings in 2021 (TTM): -โ‚น5.86 Billion

According to Flexion Therapeutics 's latest financial reports the company's current earnings are โ‚น0.10 Billion. In 2020 the company made an earning of -โ‚น8.94 Billion, an increase over its 2019 earnings that were of -โ‚น12.73 Billion.

Earnings history for Flexion Therapeutics from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-โ‚น5.86 Billion-34.44%
2020-โ‚น8.94 Billion-29.78%
2019-โ‚น12.73 Billion-13.8%
2018-โ‚น14.76 Billion21.98%
2017-โ‚น12.1 Billion79.92%
2016-โ‚น6.73 Billion53.34%
2015-โ‚น4.39 Billion69.98%
2014-โ‚น2.58 Billion51.72%
2013-โ‚น1.71 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.490 T-32,824.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.015 T-13,440.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚น0.36 B-104.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚น1.26 B-116.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-โ‚น0.99 Billion-87.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
-โ‚น0.83 Billion-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-โ‚น6.02 Billion-20.90%๐Ÿ‡บ๐Ÿ‡ธ USA